Related CAS #
74039-21-7 (HCl); 50335-55-2 (free base)
IUPAC/Chemical Name
4-Chloro-N-methyl-6-(4-methylpiperazin-1-yl)-5-methylsulfanylpyrimidin-2-amine
InChi Key
ITYXRJDDBZMFAY-UHFFFAOYSA-N
InChi Code
InChI=1S/C11H18ClN5S/c1-13-11-14-9(12)8(18-3)10(15-11)17-6-4-16(2)5-7-17/h4-7H2,1-3H3,(H,13,14,15)
SMILES Code
CSC1=C(N2CCN(C)CC2)N=C(NC)N=C1Cl
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
287.81
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Menon MK, Haddox VG. Suitability of amfonelic acid-induced locomotor stimulation in mice as a model for the evaluation of classical and atypical antipsychotics. Neuropharmacology. 1984 May;23(5):555-61. PubMed PMID: 6146108.
2: Protais P, Dubuc I, Costentin J. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats. Eur J Pharmacol. 1983 Oct 28;94(3-4):271-80. PubMed PMID: 6140175.
3: Leander JD. Interactions of clozapine, thioridazine, and mezilamine with oxotremorine on schedule-controlled responding. Psychopharmacology (Berl). 1983;80(1):29-30. PubMed PMID: 6135236.
4: Dubuc I, Protais P, Colboc O, Costentin J. Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics. Neuropharmacology. 1982 Nov;21(11):1203-6. PubMed PMID: 6129594.
5: Barghon R, Protais P, Colboc O, Costentin J. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics. Neurosci Lett. 1981 Nov 18;27(1):69-73. PubMed PMID: 6120489.
6: Neale R, Fallon S, Gerhardt S, Liebman JM. Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the "antidyskinetic" drugs, oxiperomide and tiapride. Psychopharmacology (Berl). 1981;75(3):254-7. PubMed PMID: 6798615.
7: Liebman JM, Neale R, Noreika L, Braunwalder A. Differential reversal of various dopamine antagonists by anticholinergics in Sidman avoidance: possible relationship to adrenergic blockade. Psychopharmacology (Berl). 1981;75(3):248-53. PubMed PMID: 6119730.
8: Browne RG. Anxiolytics antagonize yohimbine's discriminative stimulus properties. Psychopharmacology (Berl). 1981;74(3):245-9. PubMed PMID: 6115449.
9: Le Fur G, Mizoule J, Rataud J, Uzan A. Mezilamine, a new dopamine antagonist, blocks presynaptic but stimulates postsynaptic alpha-adrenoceptors. Eur J Pharmacol. 1979 Oct 15;58(4):359-67. PubMed PMID: 41723.
10: Uzan A, Le Fur G, Mitrani N, Kabouche M, Donadieu AM. Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties. Life Sci. 1978 Jul 17;23(3):261-73. PubMed PMID: 29181.
